{"id":"NCT01410448","sponsor":"Novartis Pharmaceuticals","briefTitle":"Everolimus in de Novo Kidney Transplant Recipients","officialTitle":"A 3-month, Multicenter, Randomized, Open Label Study to Evaluate the Impact of Early Versus Delayed Introduction of Everolimus on Wound Healing in de Novo Kidney Transplant Recipients With a Follow-up Evaluation at 12 Month After Transplant (NEVERWOUND Study)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-11","primaryCompletion":"2015-12","completion":"2015-12","firstPosted":"2011-08-05","resultsPosted":"2017-06-16","lastUpdate":"2017-06-16"},"enrollment":383,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Kidney Transplantation"],"interventions":[{"type":"DRUG","name":"Everolimus","otherNames":["Certican®"]},{"type":"DRUG","name":"Mycophenolate sodium","otherNames":["Myfortic®"]},{"type":"DRUG","name":"Cyclosporine","otherNames":["Neoral®"]},{"type":"DRUG","name":"Steroids","otherNames":[]}],"arms":[{"label":"Immediate Everolimus (IE)","type":"ACTIVE_COMPARATOR"},{"label":"Delayed Everolimus","type":"EXPERIMENTAL"}],"summary":"The purpose of this study was to evaluate whether delayed (i.e. 28 ± 4 days post-transplant) administration of everolimus after transplantation reduces the risk of wound healing complications in comparison with immediate administration in de novo renal transplant patients (proportion of patients without wound/surgical complications related to initial transplant surgery) between randomization and 3 months after transplantation.","primaryOutcome":{"measure":"Percentage of Participants Without Wound Healing Complications - Worst-case Scenario","timeFrame":"3 months","effectByArm":[{"arm":"Immediate Everolimus (IE)","deltaMin":68.39,"sd":null},{"arm":"Delayed Everolimus (DE)","deltaMin":61.58,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0921"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":22,"countries":["Italy"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":73,"n":193},"commonTop":["Anaemia","Urinary tract infection","Hypertension","Lymphocele","Hypocalcaemia"]}}